Clinical Trials Directory

Trials / Conditions / Hormone Receptor Negative Breast Carcinoma

Hormone Receptor Negative Breast Carcinoma

8 registered clinical trials studyying Hormone Receptor Negative Breast Carcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingEvolutionary Clinical Trial for Novel Biomarker-Driven Therapies
NCT07340541
UNC Lineberger Comprehensive Cancer CenterPhase 2
RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957
NiKang Therapeutics, Inc.Phase 1
TerminatedA Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NCT06264921
NiKang Therapeutics, Inc.Phase 1
RecruitingETHAN - ET for Male BC
NCT05501704
Jose Pablo LeonePhase 2
RecruitingPRE-I-SPY Phase I/Ib Oncology Platform Program
NCT05868226
QuantumLeap Healthcare CollaborativePhase 1
RecruitingFeasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cance
NCT05677802
Ohio State University Comprehensive Cancer CenterN/A
Active Not RecruitingOnvansertib + Paclitaxel In TNBC
NCT05383196
Antonio Giordano, MDPhase 1 / Phase 2
WithdrawnISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With
NCT04602117
QuantumLeap Healthcare CollaborativePhase 1